Loading...
XJPX
2378
Market cap116mUSD
Oct 09, Last price  
980.00JPY
1D
0.72%
1Q
-5.86%
Jan 2017
-34.27%
IPO
-25.19%
Name

Renaissance Inc

Chart & performance

D1W1MN
XJPX:2378 chart
P/E
—
P/S
0.29
EPS
—
Div yield, %
1.34%
Shrs. gr., 5y
1.07%
Rev. gr., 5y
16.54%
Revenues
64.93b
+1.88%
32,906,495,00035,562,412,00036,419,686,00037,048,845,00036,888,699,00038,637,134,00040,660,909,00042,031,806,00043,480,482,00044,449,012,00046,229,818,00046,070,485,00045,049,105,00030,209,649,00037,120,078,00040,760,685,00043,627,212,00063,737,043,00064,933,693,000
Net income
-2.11b
L
232,563,000181,782,000142,627,000288,229,000619,220,0001,020,670,0001,020,903,0001,446,345,0001,532,978,0001,969,652,0002,374,722,0002,436,965,0001,378,724,000-8,705,008,000513,568,000-1,141,646,000632,951,000766,000,000-2,106,745,000
CFO
4.12b
+17.44%
1,103,947,0002,683,897,0001,784,201,0002,734,070,0003,079,643,0003,482,563,0003,505,763,0003,907,396,0003,720,384,0004,369,236,0005,322,621,0005,115,877,0005,160,460,000-5,417,734,0003,819,236,0001,614,938,0004,831,805,0003,510,362,0004,122,412,999
Dividend
Mar 30, 20279 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Renaissance, Incorporated is primarily engaged in the operation of sports clubs in Japan. Its main business activities include the management of fitness clubs, swimming schools, tennis schools, and golf schools. The company also provides health promotion services to local governments and corporations, offers nursing care and rehabilitation services, and develops other related businesses.

Key people

Toshiharu Okamoto
Executive Chairman of the Board, Representative Director · since 2025
Yoshitsugu Anzawa
Chief Financial Officer, Senior Managing Executive Officer, Chief Director of Administration, Director · since 2023
Tomonori Yoshida
Senior Managing Executive Officer, Senior Chief Director of Sports Club Business, Director · since 2025
Akio Muto
Managing Executive Officer, Chief Director of Health Care Business · since 2025
Masanori Nishimura
Managing Executive Officer, Director of New Business Development · since 2023
Yukari Suzuki
Managing Executive Officer, Director of Active Aging, Director of Synapsology Research Institute, President of Subsidiary · since 2025
Tsuyoshi Higuchi
Executive Officer, Director of Health & Productivity Management Planning · since 2023
Shunsuke Hino
Executive Officer, Director of Human Resources · since 2023
Akihiro Hirano
Executive Officer, Deputy Chief Director of Marketing Promotion, Director of Communication Design, Leader of DX Promotion Project · since 2023
Michiko Kasai
Executive Officer, Director of Business Planning · since 2022
Katsuya Kumasaka
Executive Officer, Director of Community Health Promotion · since 2023
Koji Ochiai
Executive Officer, Chief Director of Sports Club Business · since 2023
Takeshi Omori
Executive Officer, Chief Director of Facility Development · since 2025
Hiroshi Sato
Executive Officer, Director of Business Development · since 2025
Koue Shibuya
Executive Officer, Director of 5th Sales · since 2025
Masanori Tanaka
Executive Officer · since 2025
Takuro Tsujioka
Executive Officer, Director of Business Support · since 2025
Tomohiro Yagi
Executive Officer, Director of Sports Club Business Planning · since 2025
Misao Mochizuki
Executive President, Chief Health Officer, Representative Director · since 2025
Toshikazu Saito
Honorary Chairman, Director · since 2025
IPO date
Dec 03, 2003
Employees
1,505
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT